Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sara A Rieke

1PUBLICATIONS

16CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 08, 2021

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.

Anne C Wilke, Carmen Doebele, Alena Zindel

Pageof 1

Frequent Collaborators

1 joint publications

Kwang Seok Lee

1 joint publications

Federico Comoglio

1 joint publications

Hanibal Bohnenberger

1 joint publications

Philipp Stauder

1 joint publications

Frank Schnütgen

1 joint publications

Björn Chapuy

1 joint publications

Christian H Brandts

1 joint publications

Philipp Stroebel

1 joint publications

Xincheng Xu

1 joint publications

Roland Schmitz

Frequent Collaborators

1 joint publications

Kwang Seok Lee

1 joint publications

Federico Comoglio

1 joint publications

Hanibal Bohnenberger

1 joint publications

Philipp Stauder

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

See more related videos

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

See more related videos